Literature DB >> 15144016

T cells of different developmental stages differ in sensitivity to apoptosis induced by extracellular NAD.

Friedrich Haag1, Dunja Freese, Felix Scheublein, Wiebke Ohlrogge, Sahil Adriouch, Michel Seman, Friedrich Koch-Nolte.   

Abstract

Extracellular nucleotides such as ATP and NAD can profoundly affect the functions of lymphocytes, macrophages, and other cells. We have recently shown that extracellular NAD induces rapid apoptosis in naive T cells by a mechanism involving the ADP-ribosylation of cell surface molecules. In the present paper, we describe that T cells of different developmental stages differ in their sensitivity to NAD-induced apoptosis. Thymocytes were less susceptible than peripheral lymph node T cells, and freshly activated cells were more resistant than resting cells. Sensitivity to NAD-induced apoptosis generally correlated with expression of the ADP-ribosyltransferase ART2.2, which is not expressed on thymocytes and shed from peripheral T cells upon activation. Our findings suggest that NAD-induced apoptosis does not play a role during thymic selection of T cells, but rather may play a role by preventing the activation of unwanted bystander T cells during an immune response, and thus may participate in the control of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 15144016      PMCID: PMC2276114          DOI: 10.1080/10446670310001593514

Source DB:  PubMed          Journal:  Dev Immunol        ISSN: 1026-7905


  10 in total

1.  Testing the role of P2X7 receptors in the development of type 1 diabetes in nonobese diabetic mice.

Authors:  Yi-Guang Chen; Felix Scheuplein; John P Driver; Amanda A Hewes; Peter C Reifsnyder; Edward H Leiter; David V Serreze
Journal:  J Immunol       Date:  2011-02-25       Impact factor: 5.422

Review 2.  Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going?

Authors:  Paul O Hassa; Sandra S Haenni; Michael Elser; Michael O Hottiger
Journal:  Microbiol Mol Biol Rev       Date:  2006-09       Impact factor: 11.056

3.  Ex Vivo Lung Perfusion with β-Nicotinamide Adenine Dinucleotide (NAD+) Improves Ischemic Lung Function.

Authors:  Jonas Peter Ehrsam; Jin Chen; Hector Rodriguez Cetina Biefer; Isabelle Opitz; Stephan Arni; Ilhan Inci
Journal:  Antioxidants (Basel)       Date:  2022-04-26

4.  A recombinant heavy chain antibody approach blocks ART2 mediated deletion of an iNKT cell population that upon activation inhibits autoimmune diabetes.

Authors:  Felix Scheuplein; Björn Rissiek; John P Driver; Yi-Guang Chen; Friedrich Koch-Nolte; David V Serreze
Journal:  J Autoimmun       Date:  2009-10-01       Impact factor: 7.094

5.  Differential regulation of P2X7 receptor activation by extracellular nicotinamide adenine dinucleotide and ecto-ADP-ribosyltransferases in murine macrophages and T cells.

Authors:  Shiyuan Hong; Nicole Schwarz; Anette Brass; Michel Seman; Friedrich Haag; Friedrich Koch-Nolte; William P Schilling; George R Dubyak
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

Review 6.  P2X7 on Mouse T Cells: One Channel, Many Functions.

Authors:  Björn Rissiek; Friedrich Haag; Olivier Boyer; Friedrich Koch-Nolte; Sahil Adriouch
Journal:  Front Immunol       Date:  2015-05-19       Impact factor: 7.561

7.  NAD+ protects against EAE by regulating CD4+ T-cell differentiation.

Authors:  Stefan G Tullius; Hector Rodriguez Cetina Biefer; Suyan Li; Alexander J Trachtenberg; Karoline Edtinger; Markus Quante; Felix Krenzien; Hirofumi Uehara; Xiaoyong Yang; Haydn T Kissick; Winston P Kuo; Ionita Ghiran; Miguel A de la Fuente; Mohamed S Arredouani; Virginia Camacho; John C Tigges; Vasilis Toxavidis; Rachid El Fatimy; Brian D Smith; Anju Vasudevan; Abdallah ElKhal
Journal:  Nat Commun       Date:  2014-10-07       Impact factor: 14.919

8.  The role of the purinergic P2X7 receptor in inflammation.

Authors:  Martin F Lister; John Sharkey; Deborah A Sawatzky; Joseph P Hodgkiss; Donald J Davidson; Adriano G Rossi; Keith Finlayson
Journal:  J Inflamm (Lond)       Date:  2007-03-16       Impact factor: 4.981

9.  Contraction of intestinal effector T cells by retinoic acid-induced purinergic receptor P2X7.

Authors:  S Hashimoto-Hill; L Friesen; M Kim; C H Kim
Journal:  Mucosal Immunol       Date:  2016-12-14       Impact factor: 7.313

Review 10.  Nicotinamide adenine dinucleotide metabolism in the immune response, autoimmunity and inflammageing.

Authors:  Maria N Navarro; Manuel M Gómez de Las Heras; Maria Mittelbrunn
Journal:  Br J Pharmacol       Date:  2021-05-12       Impact factor: 9.473

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.